Latest News and Highlights from Mayo Clinic's Center for Regenerative Biotherapeutics
The Association of Health Care Journalists (AHCJ) meets in Orlando, Florida, later this month, bringing together hundreds of reporters, producers, editors, news directors and news enthusiasts from around the world to polish the skills of their trade through educational sessions and networking. The opportunities abound for those in the medical field, including Mayo Clinic researchers and specialists who will showcase their world-class expertise during panel discussions and key presentations.
Five Mayo Clinic investigators were selected to receive 2017 Education and Biobusiness/Biotechnology Awards from Regenerative Medicine Minnesota. Regenerative Medicine Minnesota is a joint venture between the ...
This story was previously published in Discovery's Edge, Mayo Clinic's research magazine. Renaissance means rebirth or regeneration. Every few generations medicine takes a major turn. We’re at one of those junctures now with regenerative medicine — where healing is triggered from within the human body. It’s bringing a whole new universe to how physicians provide care. Deer grow, shed and then regrow their antlers. Sea stars sacrifice but then regrow their arms. This is regeneration, and every species — from amoeba to human — is inherently capable of it to some degree (think fresh, smooth skin forming below a scab).
This story was previously published in Mayo Clinic Magazine. According to a joint project of leading orthopedic societies in the United States, musculoskeletal disorders for work-related injuries account for one half of all days away from work. A decade ago, these conditions cost Americans nearly $1 trillion in health care costs and lost wages. That’s an astounding 7.4 percent of the gross domestic product in the U.S. The problem has only gotten worse since then.
After nearly a month orbiting the Earth attached to the International Space Station, the SpaceX Dragon capsule containing Dr. Abba Zubair's stem cell research detached ...
This story was previously published in Mayo Clinic Magazine. Steve Day is on a mission as he scans a crowd of about 150 people in the banquet hall of a golf course in his boyhood hometown of Sioux Falls, South Dakota. When he finally finds his target, he begins weaving through the crowd. Steve’s cane and wobbly amble are the only signs that something might be amiss with the retired grandfather. “Hi, Coach,” Steve says. “Steve Day? I can’t believe it’s you, and you’re here,” says David Kinney, Steve’s former wrestling coach who last talked to his Lincoln High pupil in 1969. Sometimes, Steve can’t believe he’s standing here either, in the aftermath of a diagnosis he formally received a little over three years ago at Mayo Clinic in Rochester, Minnesota. Steve’s balance issues, sleeping problems and irregular blood pressure stem from a rare, unusual neurodegenerative disease — multiple system atrophy.
Regenerative Medicine is an Established Priority at Mayo Clinic Five years is a short amount of time to expect results from a new strategic initiative at a complex organization. But early results were evident at the Mayo Clinic Symposium on Regenerative Medicine and Surgery. Mayo Clinic experts in regenerative medicine highlighted advancements in cancer care, cardiovascular disease, neurological conditions and musculoskeletal regeneration. More than 60 presenters from Mayo Clinic and Arizona State University shared results ranging from preliminary research to advanced discoveries in tissue engineering, cell-based therapies and cell-free therapies. The agenda included technical presentations that showed the expansive number of regenerative therapies being researched, translated and applied to patient care. The Symposium was moderated by the Center for Regenerative Medicine deputy director of education Richard Hayden, M.D.
On February 19, the latest rocket launch from NASA’s Kennedy Space Center in Cape Canaveral, Florida, included a payload of several samples of donated adult stem cells from a research laboratory at Mayo Clinic’s Florida campus. The launch by SpaceX, an American aerospace manufacturer and space transport services company, is part of NASA’s commercial resupply missions to the International Space Station. The biological cells come from the laboratory of Abba Zubair, M.D., Ph.D., who specializes in Transfusion Medicine and Regenerative Medicine. Dr. Zubair is leading regenerative medicine research to determine if healthy mesenchymal and hematopoietic stem cells, derived from the body’s bone marrow, can be mass-produced in the low-gravity environment of outer space. If the stem cells maintain their properties as they divide copiously in microgravity, they may be usable in the treatment of stroke.
Mayo Clinic’s Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) and Children’s Hospital of Philadelphia recently announced a collaboration to delay and prevent heart ...